Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
4.620
-0.020 (-0.43%)
Jul 25, 2025, 3:11 PM CST
SHE:300194 Revenue
Fuan Pharmaceutical (Group) had revenue of 467.68M CNY in the quarter ending March 31, 2025, a decrease of -42.22%. This brings the company's revenue in the last twelve months to 2.05B, down -25.90% year-over-year. In the year 2024, Fuan Pharmaceutical (Group) had annual revenue of 2.39B, down -9.68%.
Revenue (ttm)
2.05B
Revenue Growth
-25.90%
P/S Ratio
2.68
Revenue / Employee
604.29K
Employees
3,392
Market Cap
5.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.39B | -256.28M | -9.68% |
Dec 31, 2023 | 2.65B | 226.01M | 9.33% |
Jan 1, 2023 | 2.42B | -31.40M | -1.28% |
Jan 1, 2022 | 2.45B | 84.80M | 3.58% |
Dec 31, 2020 | 2.37B | -412.40M | -14.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |